Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines-Reference-Cited by-同舟云学术

Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines

Published:2007-08 Issue:4 Volume:40 Page:532-549
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif

Author:

Montanaro L.,Mazzini G.,Barbieri S.,Vici M.,Nardi-Pantoli A.,Govoni M.,Donati G.,Treré D.,Derenzini M.

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2184.2007.00448.x/fullpdf

Reference41 articles.

1. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation

2. p53 represses ribosomal gene transcription

3. Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

4. Inactivation of p53 gene in human and murine osteosarcoma cells

5. The retinoblastoma tumour suppressor in development and cancer

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histochemistry in Advanced Cytometry: From Fluorochromes to Mass Probes;Methods in Molecular Biology;2022-09-25

2. Targeting DEAD ‐box RNA helicases: The emergence of molecular staples;WIREs RNA;2022-05-17

3. Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward;Cancers;2022-04-24

4. Abemaciclib is synergistic with doxorubicin in osteosarcoma pre-clinical models via inhibition of CDK4/6–Cyclin D–Rb pathway;Cancer Chemotherapy and Pharmacology;2021-10-16

5. Identification of Prognostic RBPs in Osteosarcoma;Technology in Cancer Research & Treatment;2021-01-01